CRISPR Therapeutics to Present at Investor Conferences in May – GlobeNewswire (press release)
Chaffey Breeze |
CRISPR Therapeutics to Present at Investor Conferences in May
GlobeNewswire (press release) BASEL, Switzerland and CAMBRIDGE, Mass., May 12, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today … CRISPR: The Future of Medicine and Human Evolution China racing ahead to beat cancer with CRISPR gene editing Insider Selling: Crispr Therapeutics AG (CRSP) CEO Sells $10422.72 in Stock |
